
Spatio‐temporal graph convolutional network for diagnosis and treatment response prediction of major depressive disorder from functional connectivity
Author(s) -
Kong Youyong,
Gao Shuwen,
Yue Yingying,
Hou Zhenhua,
Shu Huazhong,
Xie Chunming,
Zhang Zhijun,
Yuan Yonggui
Publication year - 2021
Publication title -
human brain mapping
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.005
H-Index - 191
eISSN - 1097-0193
pISSN - 1065-9471
DOI - 10.1002/hbm.25529
Subject(s) - artificial intelligence , discriminative model , major depressive disorder , computer science , pooling , feature (linguistics) , graph , neuroimaging , convolutional neural network , pattern recognition (psychology) , machine learning , psychology , neuroscience , cognition , linguistics , philosophy , theoretical computer science
The pathophysiology of major depressive disorder (MDD) has been explored to be highly associated with the dysfunctional integration of brain networks. It is therefore imperative to explore neuroimaging biomarkers to aid diagnosis and treatment. In this study, we developed a spatiotemporal graph convolutional network (STGCN) framework to learn discriminative features from functional connectivity for automatic diagnosis and treatment response prediction of MDD. Briefly, dynamic functional networks were first obtained from the resting‐state fMRI with the sliding temporal window method. Secondly, a novel STGCN approach was proposed by introducing the modules of spatial graph attention convolution (SGAC) and temporal fusion. A novel SGAC was proposed to improve the feature learning ability and special anatomy prior guided pooling was developed to enable the feature dimension reduction. A temporal fusion module was proposed to capture the dynamic features of functional connectivity between adjacent sliding windows. Finally, the STGCN proposed approach was utilized to the tasks of diagnosis and antidepressant treatment response prediction for MDD. Performances of the framework were comprehensively examined with large cohorts of clinical data, which demonstrated its effectiveness in classifying MDD patients and predicting the treatment response. The sound performance suggests the potential of the STGCN for the clinical use in diagnosis and treatment prediction.